Carlo Giorda

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

Olga Vaccaro, Maria Masulli, Antonio Nicolucci et al. · The Lancet Diabetes & Endocrinology · 2017 · 285 citations

Diabetes Management, Cardiovascular Disease, Diabetes +9

Serum Uric Acid and Risk of CKD in Type 2 Diabetes

Salvatore De Cosmo, Francesca Viazzi, Antonio Pacilli et al. · Clinical Journal of the American Society of Nephrology · 2015 · 181 citations · Full text

Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins

Giorgia De Berardis, Michele Sacco, Virgilio Evangelista et al. · Trials · 2007 · 159 citations · Full text

Incidence of Coronary Heart Disease in Type 2 Diabetic Men and Women

Angelo Avogaro, Carlo Giorda, Marina Maggini et al. · Diabetes Care · 2007 · 158 citations · Full text

Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative

Giuseppina Russo, Salvatore De Cosmo, Francesca Viazzi et al. · Diabetes Care · 2016 · 148 citations · Full text